glp-1 insulin resistance Mechanism by which excessive circulating levels of may lead to GLP-1 Agonist Effects on Glucagon

Realistic Expectations for Your Journey It is helpful to remember that weight loss is rarely a perfectly linear path

Recent studies on long-acting GLP-1s in type 1 diabetes have shown promising results, including reductions in A1C levels and increased time within the target blood sugar range, without diabetic ketoacidosis or significant hypoglycemic episodes.It is well-established that elevated A1C levels can increase the risk of cardiovascular complications and kidney disease in individuals with T1D

It is important to note that tirzepatide does not yet have published cardiovascular outcomes trial data demonstrating risk reduction, and results from ongoing trials are pending

Medical history: Important to consider when prescribing weight loss injections, as pre-existing conditions can affect treatment efficacy and safety

Madisons story: Madison knows what it feels like to be stuck